Alpha BioAdvisors™ Mission

We are futurists with a vision of where new technologies will take us in segments including pharmaceuticals, AI/computational biology/tools, agriculture/food/nutrition, industrials/materials and energy/transportation – all driven by next-gen biology. As the 1st Wall Street equity analyst to cover biotechnology companies across these segments, we have a 20-year history of application knowledge that is now coming to fruition.

Knowing where the market is headed isn’t enough. We apply proven selection strategies using algorithms honed over decades of research and trading experience. Importantly, at our core, is managing risk exposure and preservation of capital.

We use a structured process that combines our proprietary quantitative models with advanced technical analyses and deep fundamental research. Our systematic process is specialized for emerging technology companies.